CN104413365A - Preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet - Google Patents
Preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet Download PDFInfo
- Publication number
- CN104413365A CN104413365A CN201310378314.0A CN201310378314A CN104413365A CN 104413365 A CN104413365 A CN 104413365A CN 201310378314 A CN201310378314 A CN 201310378314A CN 104413365 A CN104413365 A CN 104413365A
- Authority
- CN
- China
- Prior art keywords
- calusena lansium
- buccal tablet
- lansium
- digestion
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000089795 Clausena lansium Species 0.000 title abstract description 4
- 235000008738 Clausena lansium Nutrition 0.000 title abstract description 4
- 229940046011 buccal tablet Drugs 0.000 title abstract 7
- 239000006189 buccal tablet Substances 0.000 title abstract 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000010447 xylitol Nutrition 0.000 claims abstract description 20
- 239000000811 xylitol Substances 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 20
- 229960002675 xylitol Drugs 0.000 claims abstract description 20
- 235000012907 honey Nutrition 0.000 claims abstract description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 15
- 230000029087 digestion Effects 0.000 claims abstract description 14
- 210000002784 stomach Anatomy 0.000 claims abstract description 13
- 230000001737 promoting effect Effects 0.000 claims abstract description 11
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 5
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 5
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 5
- 235000006662 Lansium Nutrition 0.000 claims description 42
- 241001156382 Lansium Species 0.000 claims description 42
- 235000013399 edible fruits Nutrition 0.000 claims description 16
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 239000007937 lozenge Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 238000005728 strengthening Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 238000000748 compression moulding Methods 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 206010011224 Cough Diseases 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 208000007502 anemia Diseases 0.000 abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 3
- 239000011707 mineral Substances 0.000 abstract description 3
- 208000015220 Febrile disease Diseases 0.000 abstract description 2
- 230000001914 calming effect Effects 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract description 2
- 208000002173 dizziness Diseases 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 229960002713 calcium chloride Drugs 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- 208000026435 phlegm Diseases 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 3
- 206010019345 Heat stroke Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000019788 craving Nutrition 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet which is prepared by mainly employing clausena lansium, honey, xylitol, maltodextrin, citric acid, magnesium stearate, calcium chloride and Laoshan mountain mineral water as raw materials. The buccal tablet belongs to the technical field of health-care foodstuff, and is food mainly suitable for daily health care and digestion promotion of populations. The buccal tablet possesses the following advantages: 1) the buccal tablet has multiple efficacy of promoting digestion and fortifying stomach, resolving phlegm and calming panting, downbearing fire and helping digestion, regulating qi and relieving cough, and the like; 2) the buccal tablet is high in quality and free of side effect after being eaten for a long time; and 3) the buccal tablet is convenient to carry, and is especially eatable by patients attacked by febrile disease fever, mouth thirsty, inappetence, anaemia, dizziness, palpitaition, hypertension and the like.
Description
technical fieldthe present invention relates to a kind of preserved fruit Calusena lansium stomach strengthening and digestion promoting lozenge, the raw material used is mainly Calusena lansium, honey, xylitol, maltodextrin, citric acid, dolomol, U-Ramin MC and Laoshan Spring Water and is made.Belong to technical field of health care food.The food be mainly applicable to popular daily health caring, helping digestion.
background technologyalong with people improve constantly for the pursuit of quality of the life, healthy, green food is more and more subject to the favor of people.Particularly summer since the dog days began, heatstroke patient showed increased.Much work in the long-time environment hot at height, or the indoor that place is too sultry for a long time, be easy to cause heatstroke.Because in high temperature environments, body temperature regulatory function easily gets muddled, and the central nervous system caused is unified the acute illness of circulatory system obstacle, its main manifestations.Except high temperature, burning sun tan by the sun, working strength is excessive, overlong time, do not have enough sleep, overtired etc. be also potential inducement.Summer temperature raises, and the appetite of people is also along with changing, and now the functions of intestines and stomach of people is the most weak, and diet is careless slightly just easily causes gastrointestinal disease.In the season that this is special, diet must be noted that regulate, what this was eaten eats in right amount, should not eat and drink immoderately or go on a diet and not eat.Because hot, people always like syrup, the dessert of eating ice, have felt entrance, but do not know that the heat absorbed like this can be more.In three meals in a day, should note eating the food promoting the production of body fluid a bit and quench one's thirst more.Preserved fruit Calusena lansium is a kind of traditional folk food, in south, fresh Calusena lansium is brought back a stoning by average family, with sugar, salt is salted, it remains the multiple medical value of Calusena lansium, have food digesting stomach fortifying, resolving sputum and relieving asthma, fall the multiple efficacies such as fire is aid digestion, pleasant antibechic, Chang Zuowei snacks in summer spread extensively.Modern medicine is also thought, containing amino acid, vitamin, alkaloid, glucoside, trace element etc. in preserved fruit Calusena lansium, there is anti-inflammation, antipyreticly to drive away summer heat, produce refreshing effect to the mind, the multiple efficacies such as dispelling fatigue, and conventional as a kind of snacks, not only can satisfy craving food, also can have medical treatment, health-care effect.In order to provide a kind of more convenient, quick and there is the health food of appetite, a kind of preserved fruit Calusena lansium of the present invention stomach strengthening and digestion promoting lozenge, preserved fruit Calusena lansium is made lozenge, not only it draws materials natural, delicious flavour, medicinal efficacy is remarkable, and easy to carry, the green health lozenge that a kind of applicable summer is edible especially.
summary of the inventionthat main points of the present invention are Calusena lansium stoning to be condensed into juice is for subsequent use → and add concentrated pulping → ovens dry of all the other auxiliary materials mixing → pulverizings granulation → drying → add dolomol → compression molding → sterilizing → packaging in proportion and become a kind of preserved fruit Calusena lansium stomach strengthening and digestion promoting lozenge.
The material usage that the present invention selects following (component and percentage by weight % thereof): Calusena lansium 35.0-40.0, honey 10-20, xylitol 30.0-40.0, maltodextrin 10.0-15.0, citric acid 2.0, U-Ramin MC 1%, dolomol 4 ‰.
Calusena lansium have has eliminate fullness and oppression of chest and abdomen, promote the production of body fluid, quench the thirst, effect of pleasant, antibechic; The Calusena lansium that bitter taste is heavier, has better effect.Its bitter taste can stimulate choleresis, promotes digestion, makes absorbing function prosperous without obstacle, also has cardiotonic, and the musculus pectoralis abdominis meat that can relax again is nervous, and turgor situation is reduced or eliminates; Calusena lansium why can pleasant, antibechic, and exactly because it has lax musculus pectoralis abdominis meat stress effects, make breathing smooth and easy, do not have problem on obstacle, cough nature stops.Calusena lansium also has higher medical value, and root, leaf, fruit and seed etc. all can be used as medicine, and have the effects such as food digesting stomach fortifying, regulating qi-flowing for strengthening spleen, promoting qi circulation and relieving pain, and what custom had " hungry food lichee, Calusena lansium of being satiated with food " says.Pericarp can disappear wind swell, go infantile malnutrition due to digestive disturbances or intestinalparasites; Seed can control hernia, centipde-bite and children's's head sore.Radical Injury in Wampee Seeds is rich in oil content, and oil yield, up to 42%, is excellent lubricant.It is as a kind of fruit of high-quality, and its fruit, except eating raw, is processed into jelly, jam, preserved fruit, fruitcake and cold drink etc. or salt marsh, sugaring all has multiple benefit to human body.So, the title of " treasured in fruit " is have Calusena lansium among the people.Record at medical book, when summer eats Calusena lansium, pulp, pericarp and fruit stone can be placed in mouth and chew, connect slag band juice and swallow in the lump, though some is bitter for taste, can plays and fall the glutted effect of fire, treatment indigestion, gastral cavilty.Hot summer days travel to countryside, and summer heat compels people, if standby can be with some Calusena lansium, especially better with bitter taste Calusena lansium, thirsty or feel that brains is sultry in good time, namely chew several Calusena lansium, not only promote the production of body fluid, quench the thirst, and have the benefit of prevention heatstroke.
The effect of honey: the main component in honey is carbohydrate, it accounts for more than 3/4 of honey total amount, wherein has monosaccharide and disaccharide and polysaccharide.The summation of fructose and glucose accounts for 85% ~ 95% of honey sugar.Content of mineral substances is generally 0.04% ~ 0.06%, comprises iron, copper, potassium, sodium, tungsten, manganese, magnesium, phosphorus, silicon, lead, chromium, nickel and cobalt etc., and dark honey contains comparatively multifunctional mineral than light color honey again.Vitamin includes B family vitamin, and vitamin C, nicotinic acid, pantothenic acid, biotin, Yan acid.Protein content in honey between 0.29% ~ 1.69%, average out to 0.75%.Some seeds of flowering plants content is then up to more than 1% or 2%.In honey, not only quantity is many for amino acid whose content, and kind is also complete.Wherein with asparatate, glutamic acid, leucine for primary amino acid, secondly, as the also ubiquity in honey such as threonine, serine, glycine, alanine, valine, isoleucine, lysine.And the essential amino acid needed for people widely exists.As: threonine, valine, leucine, isoleucine, lysine.This just further illustrates the high reason place of honey nutritive value.Because honey has very high nutritive value, through modern medicine clinical practice, take honey and can promote to digest and assimilate, improve a poor appetite, calming soporific, improve the immunity of body, to the positive effect of growing promoting infant.Because the required various nutritional labeling of growing of infant, nearly all contains in honey.Particularly to faint, neurasthenia, after being ill convalescence, the empty malnutritive auxiliary curative effect that waits of old body is better.Suitable curative effect is had to diseases such as heart disease, hepatitis, anaemia, hypertension, cough, constipation, scald, frostbite, stomach and duodenums.
Xylitol: xylitol does the sweetener of diabetes patient, nutritious supplementary pharmaceutical and auxiliary therapeutical agent: xylitol is the intermediate of human body carbohydate metabolism, lack under insulin affects glycometabolism situation in vivo, need not promote by insulin, xylitol also can permeate through cell membranes, be absorbed by tissue utilization, promote liver glycogen synthesis, for cell with nutrition and energy, and blood glucose value can not be caused to raise, eliminate the symptom more than three after diabetic to take (many foods, many drinks, diuresis), be best suited for the sugar substitutes of the trophism of patients with diabetes mellitus.Xylitol can promote that liver glycogen synthesizes, and blood sugar can not rise, and be improved liver function and lipotropic effect to hepatopath, treat B-mode metastatic hepatitis, chronic hepatitis B and cirrhosis have obvious curative effects, is the desirable ancillary drug of hepatitis concurrent disease patient.Anti-caries characteristic effect in all sweeteners of xylitol is best, is first that xylitol can not be produced cariogenic bacterial fermentation and utilizes in oral cavity, suppresses the generation of streptococcus growth and acid; Secondly when chewing xylitol, salivary secretion can be promoted, saliva is many both can rinse bacterium in oral cavity, tooth, also can increase saliva and carious tooth spot place's basic amino acid and ammonia density, slow down pH value in oral cavity simultaneously and decline, the acidic materials of injury tooth are neutralized dilution, inhibit bacterium in the absorption of dental surface, thus decrease the acid etching of tooth, prevent the generation of carious tooth and minimizing dental plaque, consolidate tooth.Xylitol provides energy for human body, synthesizes glycogen, reduces the consumption of the protein in fat and hepatic tissue, liver is protected and repairs, and reduces the generation being harmful to ketoboidies in human body, can not be worry of getting fat because of edible.The fields such as food, medicine, light industry can be widely used in.Xylitol is compared with common white granulated sugar, there is the advantage that heat is low---every gram of xylitol is only containing 2.4 caloric heats, the heat few 40% of carbohydrate more most of than other, thus xylitol can be applied in various diet food, as the substitute of high heat white sugar.Metabolism is slow in vivo for biological xylitol, therefore it can not make insulin rise suddenly or decline, common sugar then can, xylitol is the natural stabiliser of insulin, food with after can not increase insulin in blood, xylitol also plays the key player of stable hormone, the horizontal insulin of high target can increase estrogen produce, cause breast cancer also to disturb the healthy functions of ovary, insulin resistance is the major reason producing hormone problem (polycystic ovary syndrome); So it is most important not only significant to resisting polycystic ovary syndrome but also reducing breast cancer to the imbalance of decomposing other hormones more to reduce insulin level.
Production technology of the present invention: Calusena lansium stoning is condensed into juice for subsequent use → add concentrated granulation → ovens dry of all the other auxiliary materials mixing → pulverizings granulation → drying → add dolomol → compression molding → sterilizing → packaging in proportion.
The preparation method of product of the present invention is:
1) pretreatment 1: the Calusena lansium of fresh harvesting is cleaned, stoning, squeezing cause soft pulpous state, it is stand-by to add 0.1% U-Ramin MC infuse;
2) hot dipping is extracted: Calusena lansium paste is put into jacketed pan, adds the Laoshan Spring Water of 30 times amount, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become Calusena lansium concentrate;
5) Calusena lansium concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
The present invention has the following advantages:
1) there are food digesting stomach fortifying, resolving sputum and relieving asthma, fall the multiple efficacies such as fire is aid digestion, pleasant antibechic;
2) Functionality, quality and appealing design, long-term eating has no side effect;
3) easy to carry, be particularly suitable for febrile disease heating, thirsty, poor appetite, anaemia, dizziness, palpitaition, hypertension, etc. edible for patients.
Detailed description of the invention: the present invention is described in further detail below in conjunction with embodiment:
For 100kg product of the present invention:
1. fill a prescription: (component and percentage by weight % thereof): Calusena lansium 35.0-40.0, honey 10-20, xylitol 30.0-40.0, maltodextrin 10.0-15.0, citric acid 2.0, U-Ramin MC 1%, dolomol 4 ‰.
2. production procedure: Calusena lansium stoning is condensed into juice for subsequent use → add concentrated granulation → ovens dry of all the other auxiliary materials mixing → pulverizings granulation → drying → add dolomol → compression molding → sterilizing → packaging in proportion.
3. preparation technology:
1) pretreatment 1: the Calusena lansium of fresh harvesting is cleaned, stoning, squeezing cause soft pulpous state, it is stand-by to add 0.1% U-Ramin MC infuse;
2) hot dipping is extracted: Calusena lansium paste is put into jacketed pan, adds the Laoshan Spring Water of 30 times amount, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become Calusena lansium concentrate;
5) Calusena lansium concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
Claims (3)
1. the present invention relates to a kind of preserved fruit Calusena lansium stomach strengthening and digestion promoting lozenge, it is characterized in that there is following formula (component and percentage by weight % thereof): Calusena lansium 35.0-40.0, honey 10-20, xylitol 30.0-40.0, maltodextrin 10.0-15.0, citric acid 2.0, U-Ramin MC 1%, dolomol 4 ‰.
2. a kind of preserved fruit Calusena lansium stomach strengthening and digestion promoting lozenge according to claim 1, is characterized in that having following production technology:
Calusena lansium stoning is condensed into juice for subsequent use → add concentrated granulation → ovens dry of all the other auxiliary materials mixing → pulverizings granulation → drying → add dolomol → compression molding → sterilizing → packaging in proportion.
3. a kind of preserved fruit Calusena lansium stomach strengthening and digestion promoting lozenge according to claim 1, is characterized in that having following preparation method:
1) pretreatment 1: the Calusena lansium of fresh harvesting is cleaned, stoning, squeezing cause soft pulpous state, it is stand-by to add 0.1% U-Ramin MC infuse;
2) hot dipping is extracted: Calusena lansium paste is put into jacketed pan, adds the Laoshan Spring Water of 30 times amount, hot water extraction's (90-100 degree) is also incubated 4 hours;
3) filter: first use 60 mesh filter screen coarse filtration, then carry out fine filtering through diatomite filter;
4) concentrated: filtrate is inputted vacuum concentration pan (vacuum 97kPa, temperature about 55), during by liquid concentration to former amount of water 1/20, become Calusena lansium concentrate;
5) Calusena lansium concentrate and other auxiliary materials are fully mixed by a certain percentage;
6) mix sufficient soft material to drop in swing granule and carry out causing grain, then particle is placed in vacuum drier carries out drying, vacuum degree control is at 0.053-0.060Mpa, and temperature controls to make the moisture of particle control be less than about 3% at 60-65 degree;
7), add lubricant (dolomol, 4 ‰) mixing in dried particles after, compressing tablet, irradiates 30 minutes under ultraviolet, then packs in time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310378314.0A CN104413365A (en) | 2013-08-28 | 2013-08-28 | Preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310378314.0A CN104413365A (en) | 2013-08-28 | 2013-08-28 | Preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104413365A true CN104413365A (en) | 2015-03-18 |
Family
ID=52964296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310378314.0A Pending CN104413365A (en) | 2013-08-28 | 2013-08-28 | Preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104413365A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104957606A (en) * | 2015-06-03 | 2015-10-07 | 李素琴 | Buccal tablets for dispelling effect of alcohol and making method of buccal tablets |
| CN104983023A (en) * | 2015-06-11 | 2015-10-21 | 钟兴欢 | Wampee digestant electuary |
-
2013
- 2013-08-28 CN CN201310378314.0A patent/CN104413365A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104957606A (en) * | 2015-06-03 | 2015-10-07 | 李素琴 | Buccal tablets for dispelling effect of alcohol and making method of buccal tablets |
| CN104983023A (en) * | 2015-06-11 | 2015-10-21 | 钟兴欢 | Wampee digestant electuary |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103229963B (en) | Coarse cereal food subjected to treatment of germination and preparation method of coarse cereal food | |
| CN102308941B (en) | Diet green coarse cereal food and preparation method thereof | |
| CN104509899A (en) | Lotus root blueberry beverage | |
| CN102726565A (en) | Tartary buckwheat-chrysanthemum health-preserving tea and preparation method thereof | |
| CN102224891A (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN103976023A (en) | Okra yogurt beverage and preparation method thereof | |
| CN101223992A (en) | Preparing method of burdock healthy drink | |
| CN102960471A (en) | Bean curd containing dragon fruit and preparation method of bean curd | |
| CN106942585A (en) | One kind relaxes bowel ground rice and preparation method thereof | |
| CN104413319A (en) | Preserved clausena-lansium stomach-invigorating digestion-promoting jelly | |
| CN106360463A (en) | Sugar-free, high-fiber and high-protein siraitia grosvenorii convenient food and preparation method thereof | |
| CN1935036A (en) | Aloe-sea buckthorn nutrient health drink and its prepairng method | |
| CN104116117A (en) | Weight-reducing and health beverage | |
| CN102106577B (en) | Natural and organic beverage capable of improving male sleep quality | |
| CN104413238A (en) | Preserved clausena lansium throat sugar | |
| CN105341300A (en) | Health-care candies suitable for children to eat | |
| CN101099526A (en) | Ginseng flower health tea drink and its preparing method | |
| CN102273687A (en) | Rose and wax apple beverage and preparation method thereof | |
| CN104413365A (en) | Preserved clausena-lansium stomach-invigorating digestion-promoting buccal tablet | |
| CN104161120A (en) | Milk tea with randia cochinchinensis fruits | |
| CN100456966C (en) | Health drink for heat-clearing and fire-reducing | |
| CN102885364A (en) | Corn beverage and its preparation method | |
| CN104738387A (en) | Preparation method of Korean red ginseng-soybean protein puffed powder | |
| CN108685101A (en) | Wood frog peptide inulin | |
| CN104366179A (en) | Manufacturing method of water lily stomach-strengthening lozenge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150318 |
|
| WD01 | Invention patent application deemed withdrawn after publication |